Ming-Ming He

958 total citations
11 papers, 256 citations indexed

About

Ming-Ming He is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ming-Ming He has authored 11 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Ming-Ming He's work include Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Ming-Ming He is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Ming-Ming He collaborates with scholars based in China and United States. Ming-Ming He's co-authors include Rui‐Hua Xu, Dong-sheng Zhang, Feng-Hua Wang, Hui Luo, Miao‐Zhen Qiu, Yu-Hong Li, Zhao-Lei Zeng, Long Bai, De‐Shen Wang and Chao Ren and has published in prestigious journals such as PLoS ONE, Medicine and Oncotarget.

In The Last Decade

Ming-Ming He

11 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Ming He China 9 149 86 77 76 64 11 256
Jean Philippe Metges France 8 224 1.5× 124 1.4× 85 1.1× 76 1.0× 110 1.7× 23 343
Irene Pecora Italy 9 130 0.9× 99 1.2× 75 1.0× 32 0.4× 32 0.5× 24 207
Ana León Spain 9 196 1.3× 70 0.8× 45 0.6× 101 1.3× 72 1.1× 23 260
T.W. Kim South Korea 8 226 1.5× 93 1.1× 76 1.0× 38 0.5× 32 0.5× 26 264
C. Julié France 10 224 1.5× 88 1.0× 113 1.5× 48 0.6× 35 0.5× 23 310
Aamir Ali Syed Pakistan 9 134 0.9× 66 0.8× 148 1.9× 45 0.6× 28 0.4× 55 278
Michela Lia Italy 9 147 1.0× 249 2.9× 33 0.4× 70 0.9× 112 1.8× 15 328
Loretta Sullivan United States 3 159 1.1× 107 1.2× 55 0.7× 111 1.5× 40 0.6× 4 258
Susie Bae Australia 10 189 1.3× 135 1.6× 59 0.8× 54 0.7× 28 0.4× 32 274

Countries citing papers authored by Ming-Ming He

Since Specialization
Citations

This map shows the geographic impact of Ming-Ming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Ming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Ming He more than expected).

Fields of papers citing papers by Ming-Ming He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Ming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Ming He. The network helps show where Ming-Ming He may publish in the future.

Co-authorship network of co-authors of Ming-Ming He

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Ming He. A scholar is included among the top collaborators of Ming-Ming He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Ming He. Ming-Ming He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Wang, Zixian, Hao‐Xiang Wu, Li Xie, et al.. (2019). Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors. JAMA Network Open. 2(5). e193433–e193433. 12 indexed citations
3.
Wang, Zixian, Ming-Ming He, Jing‐Ping Yun, et al.. (2018). Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy. Journal of Cancer. 9(4). 660–666. 13 indexed citations
4.
5.
Wang, Zixian, Ming-Ming He, Feng Wang, et al.. (2016). The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy. Medicine. 95(16). e3214–e3214. 3 indexed citations
6.
He, Ming-Ming, Dong-sheng Zhang, Feng Wang, et al.. (2016). Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway. Cancer Chemotherapy and Pharmacology. 79(1). 69–79. 2 indexed citations
7.
Wei, Xiao-Li, Miao‐Zhen Qiu, Ming-Ming He, et al.. (2016). The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy. Oncotarget. 7(46). 75094–75103. 24 indexed citations
8.
Wang, Feng, Long Bai, Ming-Ming He, et al.. (2015). Right- and left-sided colorectal cancers respond differently to cetuximab. Chinese Journal of Cancer. 34(3). 384–93. 57 indexed citations
9.
Wei, Xiao-Li, Dong-sheng Zhang, Ming-Ming He, et al.. (2015). The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma. Tumor Biology. 37(2). 1879–1887. 36 indexed citations
10.
Chen, Dong-liang, Dong-sheng Zhang, Yun-Xin Lu, et al.. (2015). microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Oncotarget. 6(13). 10868–10879. 62 indexed citations
11.
He, Ming-Ming, Wen-jing Wu, Feng Wang, et al.. (2013). S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis. PLoS ONE. 8(12). e82798–e82798. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Philippe Metges Breakdown of academic impact, for papers by Irene Pecora Breakdown of academic impact, for papers by Ana León Breakdown of academic impact, for papers by T.W. Kim Breakdown of academic impact, for papers by C. Julié Breakdown of academic impact, for papers by Aamir Ali Syed Breakdown of academic impact, for papers by Michela Lia Breakdown of academic impact, for papers by Loretta Sullivan Breakdown of academic impact, for papers by Susie Bae
Rankless by CCL
2026